Company profile
Disrupt Therapeutics S.L.
Advancing treatment for cannabis addiction
- Industry
- Biotechnology Research
- Employees
- 5
Disrupt Therapeutics S.L. company summary
Disrupt Therapeutics S.L. is a company in the Biotechnology Research industry. On LinkedIn the company has around 5 employees.
What technology does Disrupt Therapeutics S.L. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Disrupt Therapeutics S.L.
Disrupt Therapeutics S.L., founded in Barcelona in 2023, is a pioneering biotech company focused on the preclinical and clinical development of a groundbreaking peptide-based drug. This novel therapeutic agent aims to counteract the harmful effects of cannabinoids, offering a solution for cannabis addiction while also mitigating the side effects experienced by chronic pain patients using medical cannabis.
Compare companies similar to Disrupt Therapeutics S.L.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Disrupt Therapeutics S.L. disrupttherapeutics.com | Biotechnology Research | 5 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Disrupt Therapeutics S.L.
What does Disrupt Therapeutics S.L. do?
Disrupt Therapeutics S.L., founded in Barcelona in 2023, is a pioneering biotech company focused on the preclinical and clinical development of a groundbreaking peptide-based drug. This novel therapeutic agent aims to counteract the harmful effects of cannabinoids, offering a solution for cannabis addiction while also mitigating the side effects experienced by chronic pain patients using medical cannabis.
How many employees does Disrupt Therapeutics S.L. have?
Disrupt Therapeutics S.L. has around 5 employees on LinkedIn.
Build a lead list from companies like Disrupt Therapeutics S.L.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.